AMNEAL PHARMACEUTICALS, INC. Prepaid Expense and Other Assets, Current
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Prepaid Expense and Other Assets, Current of $112.01 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-06
- 2026-06-30: Prepaid Expense and Other Assets, Current $112.01M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $103.09M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $98.39M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $101.51M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $112.01M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $103.09M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $98.39M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $101.51M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $85.30M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $88.52M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $80.72M 10-K · filed 2026-02-27 |
| 2024-09-30 | $81.96M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $81.60M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $87.30M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $82.69M 10-K · filed 2025-02-28 |
| 2023-09-30 | $91.44M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $81.76M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $81.42M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $103.56M 10-K · filed 2024-03-14 |
| 2022-09-30 | $149.65M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $232.20M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $121.41M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $110.22M 10-K · filed 2023-03-03 |
| 2021-09-30 | $110.21M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $103.80M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $75.14M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $73.47M 10-K · filed 2022-03-01 |
| 2020-09-30 | $76.26M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $184.75M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $204.41M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $70.16M 10-K · filed 2021-03-01 |
| 2019-09-30 | $66.70M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $77.06M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $111.56M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $128.32M 10-K · filed 2020-03-02 |
| 2018-09-30 | $126.39M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $139.60M 10-Q · filed 2018-08-09 |
| 2017-12-31 | $42.40M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |